Valuation: Danaher Corporation

Market Cap 155B 138B 128B 117B 220B 14,955B 221B 1,545B 605B 7,624B 580B 568B 24,467B P/E 2026 *
37.4x
P/E 2027 * 30.4x
Enterprise Value 175B 156B 145B 132B 250B 16,948B 251B 1,751B 686B 8,641B 658B 643B 27,729B EV / Sales 2026 *
6.65x
EV / Sales 2027 * 5.99x
Free-Float
70.44%
Yield 2026 *
0.65%
Yield 2027 * 0.71%
1 day+1.08%
1 week+2.69%
Current month-0.79%
1 month+7.30%
3 months+12.16%
6 months+13.90%
Current year-3.98%
1 week 211.72
Extreme 211.715
227.61
1 month 199.09
Extreme 199.09
228.38
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer - 30/09/2026
Director of Finance/CFO - 27/02/2026
Chief Tech/Sci/R&D Officer - 24/08/2025
Director TitleAgeSince
Director/Board Member 74 30/06/1999
Chairman 74 31/12/1983
Director/Board Member 69 31/12/1983
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Other

SVP, Chief Strategy Officer

59,816 0.0085% -
21/08/26 Sell

Chief Executive Officer

-58,255 0.0083%
04/08/26 Free

Chief Technology Officer

13,477 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%+2.69%+7.50%+0.66% 153B
+0.93%+0.49%+23.07%+32.63% 241B
+2.06%+8.17%-4.46%+43.96% 147B
+1.64%+0.31%-56.08%-18.45% 60.93B
+1.15%+0.07%+13.33%+16.89% 48.56B
+2.30%+4.07%-19.37%-17.50% 47.69B
+1.41%+1.65%+21.72%+53.25% 47.41B
+3.96%+8.34%-0.78%+38.92% 46.12B
+1.08%+2.01%+31.27%+62.47% 42.16B
+5.14%+1.88%+188.41%+101.88% 39.95B
Average +2.08%+0.29%+20.46%+31.47% 87.35B
Weighted average by Cap. +1.67%+0.42%+13.96%+27.82%

Financials

2026 *2027 *
Net sales 26.35B 23.54B 21.89B 19.91B 37.6B 2,550B 37.76B 264B 103B 1,300B 98.96B 96.79B 4,173B 28.49B 25.44B 23.67B 21.53B 40.64B 2,757B 40.82B 285B 112B 1,406B 107B 105B 4,510B
Net income 4.18B 3.73B 3.47B 3.16B 5.96B 405B 5.99B 41.8B 16.38B 206B 15.7B 15.36B 662B 5.14B 4.59B 4.27B 3.88B 7.33B 497B 7.36B 51.39B 20.14B 254B 19.3B 18.88B 814B
Net Debt 20.6B 18.4B 17.11B 15.57B 29.39B 1,994B 29.52B 206B 80.7B 1,016B 77.35B 75.66B 3,262B 16.19B 14.46B 13.45B 12.23B 23.1B 1,567B 23.2B 162B 63.43B 799B 60.79B 59.46B 2,563B
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
09/10/26 US$219.81 +1.08% 3,185,000
08/10/26 US$217.46 -0.47% 5,293,222
07/10/26 US$218.49 +1.34% 3,974,177
06/10/26 US$215.61 -2.53% 3,642,563
05/10/26 US$221.21 +3.34% 3,093,907
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
219.81USD
Average target price
241.00USD
Spread / Average Target
+9.64%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Danaher Corporation